PALB2 mutations and prostate cancer risk and survival. Wokolorczyk D, Kluzniak W, Stempa K, Rusak B, et al. Br J Cancer 2021 May 18. pii: 10.1038/s41416-021-01410.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wokolorczyk D, Kluzniak W, Stempa K, Rusak B, et al. PALB2 mutations and prostate cancer risk and survival. Br J Cancer 2021 May 18. pii: 10.1038/s41416-021-01410.
PMID: 34006922